Status:
COMPLETED
Enhance Access to Kidney Transplantation and Living Kidney Donation
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Institute for Clinical Evaluative Sciences (ICES)
Canadian Institutes of Health Research (CIHR)
Conditions:
Kidney Diseases
Kidney Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Compared to dialysis, kidney transplantation is associated with improved survival, better quality of life and substantial cost savings to healthcare systems. Despite these advantages, many individuals...
Detailed Description
1. Statement of the health problem or issue: Compared with dialysis, a kidney transplant offers patients a better quality of life and many gain 10 or more years of life expectancy. A transplant also c...
Eligibility Criteria
Inclusion
- This is a pragmatic, two-arm, parallel-group, open-label, registry-based cluster randomized, superiority, clinical trial with eligibility criteria detailed below.
- All 26 chronic kidney disease (CKD) programs in Ontario. These programs provide care for all chronic dialysis patients in the province. Each CKD program also provides a multi-care kidney clinic for patients with advanced CKD who are approaching the need for dialysis.
Exclusion
- None. Including all Ontario CKD programs.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03329521
Start Date
November 1 2017
End Date
December 31 2021
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A5W9